SEC Form 4 · accession 0001102624-15-000116
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Jan 27, 2015
Accepted (ET)
Jan 29, 2015 · 3:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 27, 2015 | P | 200 | $0.39 | A | 7,544,285 | D | |
| Common Stock | Jan 27, 2015 | P | 200 | $0.42 | A | 7,544,485 | D | |
| Common Stock | Jan 27, 2015 | P | 200 | $0.509 | A | 7,544,685 | D | |
| Common Stock | Jan 28, 2015 | P | 200 | $0.4799 | A | 7,544,885 | D |
Table II — derivative securities
No Table II lines on this filing.